loading
WELCOME TO SMART METABOAI

Investment Opportunity

MetaboAI helps reduce long-term healthcare costs by improving metabolic control through early, sustainable behavior change rather than late, reactive treatment..

Economic Impact

MetaboAI targets a large and growing market at the intersection of AI, chronic disease management, and preventive healthcare. With a scalable, data-driven platform and clear revenue paths through subscriptions, partnerships, and clinical programs, MetaboAI is positioned for strong margins, recurring revenue, and long-term growth.

Diabetes Is a Cost Crisis

  • In the U.S., over 38 million adults live with diabetes, roughly 1 in 10.
  • 537 million adults worldwide live with diabetes today
  • Projected to reach 643 million by 2030
  • Investor insight: This is not a niche market. It is one of the largest and fastest-growing chronic health segments globally.

    • timelines
    38 M

    $412 Billion in Annual U.S. Healthcare Costs

  • Diabetes costs the U.S. $412B per year
  • $306B in direct medical costs
  • $106B in lost productivity
  • Average person with diabetes spends 2.3× more on healthcare than someone without
  • Investor insight: Even modest improvements in glucose control represent enormous cost-savings potential for payers, employers, and individuals.

    • timelines
    $412 B

    Most Complications Are Preventable

    Studies show that 5–10% A1C reduction can significantly lower risk of:

  • Cardiovascular disease
  • Kidney failure
  • Neuropathy and amputations
  • Yet most patients receive reactive care, not daily guidance
  • Investor insight: Prevention and behavior-change tools remain under-served, creating a clear opportunity for AI-driven, low-cost intervention.

    • timelines
    5-10%

    MetaboAI Targets the Gap

  • Daily decision support, not episodic care
  • Turns CGM and habit data into simple, actionable steps
  • Focused on early intervention, consistency, and habit formation
  • Potential healthcare savings of $1,000–$4,000 per user per year.
  • Investor insight: MetaboAI sits at the intersection of AI, chronic care, and preventive health, addressing a multi-hundred-billion-dollar problem with scalable software.

    • timelines
    $4000